Enhancing Imaging Capabilities with Breast Tomosynthesis

Siemens HealthcareSiemens Healthcare has now integrated 3D tomosynthesis into its Mammomat Inspiration digital mammography platform. This technology compiles three-dimensional images of the breast and can therefore detect tumors even if hidden by overlapping tissue. This enables a more accurate diagnosis than before and reduces the number of false positive findings. The first Mammomat systems with tomosynthesis have now been installed in Germany and in Belgium.

Dr. Renate Tewaag from Radprax - a group of practices specializing in radiology, nuclear medicine and radiation therapy - was the first radiologist in Germany to use this new Siemens technology. "With tomosynthesis we are witnessing a fascinating further development in digital mammography. This 3D technology offers impressive improvements in the detection of detail, which benefit both patients and radiologists alike: We can be more certain in our diagnosis, while women being examined can feel more reassured", explained Dr. Tewaag. "Tomosynthesis makes mammography less stressful for both the physician and patient. Based on current first impressions, additional examinations and interventions can be avoided with a clear conscience. Lesions hidden within the dense glandular tissue are identified at an earlier stage."

So far, conventional analog mammography and digital full-field mammography was only able to display the three-dimensional anatomical structure of the breast on a two-dimensional level. This made diagnosis more difficult and limited the possibility of the physician identifying certain types of tumor; since, anatomical structures could overlap and obscure lesions. The 3D tomosynthesis technology in the Mammomat Inspiration overcomes these limitations: The technology acquires several projections of the breast from different angles using a fast detector based on amorphous Selenium (aSe) and uses this raw data to generate a 3D volume set. This enables a better analysis of the type and size of lesions as well as microcalcifications compared to conventional methods.

Tomosynthesis increases the sensitivity and specificity of mammography, as well as improving tumor differentiation and classification.

Tomosynthesis differs from conventional mammography in the same way that, for example, a CT scan (computer tomography) differs from a classical X-ray image. During the examination, the Xray tube moves in a 50-degree arc around the breast, taking 25 low-dose images. The images are then used as raw data to construct high-resolution 3D images. High spatial resolution and a wide acquisition angle result in the production of mammography images with unparalleled image quality.

The digital Mammomat Inspiration system with basic screening and diagnostic functions has been on the market since the end of 2007 and is widely used in hospitals and medical practices around the world. Mammomat Inspiration offers screening, diagnostics, stereotactic biopsy, and now tomosynthesis for the first time together on a single integrated digital platform. Any hospital or practice can purchase a screening device and add the biopsy and 3D tomosynthesis applications at a later time if necessary. Soon, all installed systems of this type can be upgraded on-site with the tomosynthesis function.

Related news articles:

About The Siemens Healthcare
The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens is the only company to offer customers products and solutions for the entire range of patient care from a single source - from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 49,000 employees worldwide and operates in over 130 countries. In fiscal year 2008 (to September 30), the Sector posted revenue of 11.2 billion euros and profit of 1.2 billion euros. For further information please visit: www.siemens.com/healthcare.

Most Popular Now

Researchers Find Telemedicine may Help R…

Low-value care - medical tests and procedures that provide little to no benefit to patients - contributes to excess medical spending and both direct and cascading harms to patients. A...

AI may Help Clinicians Personalize Treat…

Individuals with generalized anxiety disorder (GAD), a condition characterized by daily excessive worry lasting at least six months, have a high relapse rate even after receiving treatment. Artificial intelligence (AI)...

Accelerating NHS Digital Maturity: Paper…

Digitised clinical noting at South Tees Hospitals NHS Foundation Trust is creating efficiencies for busy doctors and nurses. The trust’s CCIO Dr Andrew Adair, deputy CCIO Dr John Greenaway, and...

Mobile App Tracking Blood Pressure Helps…

The AHOMKA platform, an innovative mobile app for patient-to-provider communication that developed through a collaboration between the School of Engineering and leading medical institutions in Ghana, has yielded positive results...

Can AI Help Detect Cognitive Impairment?

Mild cognitive impairment (MCI) can be an early indicator of Alzheimer's disease or dementia, so identifying those with cognitive issues early could lead to interventions and better outcomes. But diagnosing...

AI can Open Up Beds in the ICU

At the height of the COVID-19 pandemic, hospitals frequently ran short of beds in intensive care units. But even earlier, ICUs faced challenges in keeping beds available. With an aging...

Customized Smartphone App Shows Promise …

A growing body of research indicates that older adults in assisted living facilities can delay or even prevent cognitive decline through interventions that combine multiple activities, such as improving diet...

New Study Shows Promise for Gamified mHe…

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of More Stamina, a gamified mobile health (mHealth) app designed to help people with Multiple Sclerosis (MS)...

AI Model Predicting Two-Year Risk of Com…

AFib (short for atrial fibrillation), a common heart rhythm disorder in adults, can have disastrous consequences including life-threatening blood clots and stroke if left undetected or untreated. A new study...

Patients' Affinity for AI Messages …

In a Duke Health-led survey, patients who were shown messages written either by artificial intelligence (AI) or human clinicians indicated a preference for responses drafted by AI over a human...

New Research Explores How AI can Build T…

In today’s economy, many workers have transitioned from manual labor toward knowledge work, a move driven primarily by technological advances, and workers in this domain face challenges around managing non-routine...

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...